Chronic anterior uveitis in a patient with CREST syndrome

Autor: Sara Fuente Cosío, Beatriz Arca Barca, Paula Martínez García, Antonio Sampedro López

Publikováno v: Reumatología Clínica (English Edition). 16:497-498

Systemic sclerosis is a connective tissue pathology with very heterogeneous clinical manifestations, associated in a small percentage with inflammatory eye diseases. In the specific case of uveitis, only isolated cases have been reported in the liter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf928376b51efad9fa97d3a559ff1bc5
https://doi.org/10.1016/j.reumae.2018.10.021

FRI0277 ISCHEMIC AND SYSTEMIC SYMPTOMS IN GIANT CELL ARTERITIS PATIENTS, RESPONSE TO TOCILIZUMAB

Autor: Sara Manrique Arija, Pau Lluch, Alejandro Olivé, María Álvarez del Buergo, J. Luis Hernández, Clara Moriano, Juan Carlos Nieto, Javier Loricera, Arantxa Conesa, Marcelino Revenga, Elena Aurrecoechea, Rafael Melero, Vanesa Calvo-Río, Paloma Vela-Casasempere, Miguel A. González-Gay, C. Hidalgo, Catalina Gomez-Arango, Elena Becerra-Fernández, Raquel Dos-Santos, Antonio García, Diana Prieto-Peña, Francisca Sivera, María Varela-García, Carles Galisteo, Natalia Palmou-Fontana, Santos Castañeda, Beatriz Arca, I. Villa-Blanco, Montserrat Corteguera, Eva Salgado-Pérez, A. Humbría, Luisa Marena Rojas, Ricardo Blanco, Norberto Ortego, Roser Solans-Laqué, Francisco Ortiz-Sanjuán, Eugenio de Miguel, Eva Galindez, José Andrés Román-Ivorra, Alfonso Corrales, Enrique Raya, Carlos Vázquez, Carmen Torres-Martín, Ángel García-Manzanares, Francisco Navarro, J Francisco, Monica Calderón-Goercke, Noelia Alvarez-Rivas, Susana Romero-Yuste, Carmen Ordas-Calvo, Carlos Fernández-López, N. Fernández-Llanio, Carmen Larena, Sabela Fernández, Eva Perez-Pampin, Cristina Luna-Gomez, Carmen González-Vela, Vicente Aldasoro, Javier Narváez, Toyos Sáenz de Miera

Publikováno v: Poster Presentations.

Background In Giant Cell Arteritis (GCA) two dominant cytokine clusters have been linked to disease activity, IL-6 – IL-17 axis (Th17) and IL-12 – IFN γ axis (Th1). The first one related to systemic symptoms and the second route responsible for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1af56b2bb22928fb7ae8931b4ea31e4f
https://doi.org/10.1136/annrheumdis-2019-eular.2230

AB0762 TREATMENT WITH TOFACITINIB IN REFRACTORY PSORIATIC ARTHRITIS. MULTICENTER STUDY OF CLINICAL PRACTICE

Autor: Belén Atienza-Mateo, Esteban Rubio Romero, Ricardo Blanco, Miguel A. González-Gay, Luis Fernández-Dominguez, B. Joven-Ibáñez, Beatriz Arca, Alfonso Corrales, Clara Ventin-Rodriguez, José Luis Martín-Varillas, Jose Campos Esteban, Antia Crespo Golmar, Francisco Ortiz-Sanjuán, Maria Jose Moreno, Manuel Moreno, Eva Galindez, O. Maíz, Rafael Melero, Agusti Sellas-Fernández, Raul Veroz Gonzalez, Enrique Raya, Roberto Daniel Gonzalez Benitez, Olga Rusinovich, Alejandro Escudero Contreras, Emma Beltrán, Vanesa Calvo-Río, Natalia Palmou-Fontana, Javier Loricera, Ximena Elizabeth Larco Rojas, María-Luisa Peral

Publikováno v: Abstracts accepted for Publication.

Background: Tofacitinib (TOFA) is the first inhibitor of JAK kinases with approval for the treatment of psoriatic arthritis (PsA) in Europe (July 2018)1. ToFA has shown efficacy in refractory patients to anti-TNF2. Objectives: A) to assess efficacy a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6bacfa1479a5769dfa23f37f5a822b1c
https://doi.org/10.1136/annrheumdis-2019-eular.7803

SAT0220 USE OF TOCILIZUMAB IN AORTITIS. A MULTICENTER STUDY OF 79 PATIENTS

Autor: Ricardo Blanco, Beatriz Arca, Clara Moriano, Eva Salgado-Pérez, María Varela-García, Rafael Melero, Pau Lluch, J Francisco, Carmen González-Vela, Francisca Sivera, Vicente Aldasoro, Noelia Alvarez-Rivas, Alfonso Corrales, Raquel Dos-Santos, I. Villa-Blanco, Javier Loricera, Susana Romero-Yuste, Marcelino Revenga, Miguel A. González-Gay, Eva Perez-Pampin, Carlos Vázquez, José Luis Martín-Varillas, Toyos Sáenz de Miera, Sabela Fernández, Cristina Luna-Gomez, N. Fernández-Llanio, Carmen Larena, Elena Aurrecoechea, Antonio García, Natalia Palmou-Fontana, Santos Castañeda, Roser Solans-Laqué, Eva Galindez, A. Humbría, María Álvarez del Buergo, Catalina Gomez-Arango, Luisa Marena Rojas, Diana Prieto-Peña, J. Luis Hernández, J.A. Narváez, Vanesa Calvo-Río, Monica Calderón-Goercke

Publikováno v: Saturday, 15 June 2019.

Background Aortitis can be idiopathic or associated with other conditions. It is frequently refractory to conventional immunosuppressive therapy. Tocilizumab (TCZ), an anti-IL-6 receptor antibody seems to be effective and safe. Objectives Our aim was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::85f09eb9f60f9e2de1098432f06c193d
https://doi.org/10.1136/annrheumdis-2019-eular.3571

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Autor: C. Hidalgo, María Varela-García, Carles Galisteo, Santos Castañeda, Susana Romero-Yuste, Noelia Alvarez-Rivas, Raquel Dos Santos, Carmen González-Vela, José L. Hernández, Rafael Melero, Carlos Fernández-López, Sabela Fernández, Francisco Ortiz-Sanjuán, Vicente Aldasoro, Clara Moriano, N. Fernández-Llanio, Paloma Vela, Francisca Sivera, Alejandro Olivé-Marqués, Carmen Ordas-Calvo, Eva Galíndez-Agirregoikoa, Alfonso Corrales, Enrique Raya, Ricardo Blanco, Eugenio de Miguel, Diana Prieto-Peña, Carlos Vázquez, Vanesa Calvo-Río, Elena Aurrecoechea, Carmen Larena, Ángel García-Manzanares, Miguel A. González-Gay, Elena Becerra-Fernández, Marcelino Revenga, Antonio García, Eva Perez-Pampin, María Álvarez del Buergo, José Andrés Román-Ivorra, Natalia Palmou-Fontana, Juan Carlos Nieto, Luisa Marena-Rojas, Montserrat Corteguera, F. Javier Toyos-Sáenz de Miera, Cristina Luna-Gomez, Sara Manrique-Arija, Catalina Gomez-Arango, Monica Calderón-Goercke, Roser Solans-Laqué, Carmen Torres-Martín, Beatriz Arca, Eva Salgado-Pérez, Ignacio Villa, Norberto Ortego, Javier Narváez, A. Humbría, Pau Lluch, Francisco Navarro, Javier Loricera, Arantxa Conesa

Publikováno v: SEMINARS IN ARTHRITIS AND RHEUMATISM
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Semin Arthritis Rheum. 2019 Aug;49(1):126-135
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)

Objective: Tocilizumab (TCZ) has shown efficacy in clinical trials on giant cell arteritis (GCA). Real-world data are scarce. Our objective was to assess efficacy and safety of TCZ in unselected patients with GCA in clinical practice Methods: Observa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a21d5a02db953c023245fb1b796fa8c9
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7994